Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Molecular Genetics and Metabolism Reports
|
May 29, 2020
Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10
Lalitha R Belur, Kelly M Podetz-Pedersen, Thuy An Tran, et al.
Frontiers in Pain Research (Lausanne, Switzerland)
|
February 26, 2024
Adeno-associated virus-mediated gene transfer of arginine decarboxylase to the central nervous system prevents opioid analgesic tolerance
Caroline C Churchill, Cristina D Peterson, Kelley F Kitto, et al.
Molecular Cancer
|
February 12, 2011
Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System
Lalitha R Belur, Kelly M Podetz-Pedersen, Brent S Sorenson, et al.
Molecular Pain
|
June 1, 2010
Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture
Lucy Vulchanova, Daniel J Schuster, Lalitha R Belur, et al.
Frontiers in Neuroanatomy
|
August 23, 2014
Supraspinal gene transfer by intrathecal adeno-associated virus serotype 5
Daniel J Schuster, Lalitha R Belur, Maureen S Riedl, et al.
Molecular Genetics and Metabolism Reports
|
January 27, 2023
Non-invasive intravenous administration of AAV9 transducing iduronate sulfatase leads to global metabolic correction and prevention of neurologic deficits in a mouse model of Hunter syndrome
Kanut Laoharawee, Kelly M Podetz-Pedersen, Tam T Nguyen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 17, 2005
Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expression
Paul R Score, Lalitha R Belur, Joel L Frandsen, et al.
The Journal of Gene Medicine
|
April 5, 2007
Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon-mediated gene delivery: implications for non-viral gene therapy of mucopolysaccharidoses
Elena L Aronovich, Jason B Bell, Lalitha R Belur, et al.
Molecular Genetics and Metabolism
|
April 6, 2023
Generation and characterization of an immunodeficient mouse model of mucopolysaccharidosis type II
Miles C Smith, Lalitha R Belur, Andrea D Karlen, et al.
Molecular Therapy. Methods & Clinical Development
|
February 20, 2024
Comparative dose effectiveness of intravenous and intrathecal AAV9.CB7.hIDS, RGX-121, in mucopolysaccharidosis type II mice
Miles C Smith, Lalitha R Belur, Andrea D Karlen, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Molecular Genetics and Metabolism Reports
|
May 29, 2020
Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10
Lalitha R Belur, Kelly M Podetz-Pedersen, Thuy An Tran, et al.
Frontiers in Pain Research (Lausanne, Switzerland)
|
February 26, 2024
Adeno-associated virus-mediated gene transfer of arginine decarboxylase to the central nervous system prevents opioid analgesic tolerance
Caroline C Churchill, Cristina D Peterson, Kelley F Kitto, et al.
Molecular Cancer
|
February 12, 2011
Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System
Lalitha R Belur, Kelly M Podetz-Pedersen, Brent S Sorenson, et al.
Molecular Pain
|
June 1, 2010
Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture
Lucy Vulchanova, Daniel J Schuster, Lalitha R Belur, et al.
Frontiers in Neuroanatomy
|
August 23, 2014
Supraspinal gene transfer by intrathecal adeno-associated virus serotype 5
Daniel J Schuster, Lalitha R Belur, Maureen S Riedl, et al.
Molecular Genetics and Metabolism Reports
|
January 27, 2023
Non-invasive intravenous administration of AAV9 transducing iduronate sulfatase leads to global metabolic correction and prevention of neurologic deficits in a mouse model of Hunter syndrome
Kanut Laoharawee, Kelly M Podetz-Pedersen, Tam T Nguyen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 17, 2005
Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expression
Paul R Score, Lalitha R Belur, Joel L Frandsen, et al.
The Journal of Gene Medicine
|
April 5, 2007
Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon-mediated gene delivery: implications for non-viral gene therapy of mucopolysaccharidoses
Elena L Aronovich, Jason B Bell, Lalitha R Belur, et al.
Molecular Genetics and Metabolism
|
April 6, 2023
Generation and characterization of an immunodeficient mouse model of mucopolysaccharidosis type II
Miles C Smith, Lalitha R Belur, Andrea D Karlen, et al.
Molecular Therapy. Methods & Clinical Development
|
February 20, 2024
Comparative dose effectiveness of intravenous and intrathecal AAV9.CB7.hIDS, RGX-121, in mucopolysaccharidosis type II mice
Miles C Smith, Lalitha R Belur, Andrea D Karlen, et al.
Page
of 7